Cargando…

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease

The inflammatory response at infliximab (IFX) treatment failure due to tumor necrosis factor (TNF)-α-independent Crohn disease activity is unknown. This is an exploratory, hypothesis-generating study based on samples collected in a clinical trial among patients failing conventional IFX dosages and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steenholdt, Casper, Coskun, Mehmet, Buhl, Sine, Bendtzen, Klaus, Ainsworth, Mark A., Brynskov, Jørn, Nielsen, Ole H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845836/ https://www.ncbi.nlm.nih.gov/pubmed/27100432 http://dx.doi.org/10.1097/MD.0000000000003417

Ejemplares similares

Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial
por: Buhl, Sine Schnoor, et al.
Publicado: (2014)

Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
por: Nielsen, Ole Haagen, et al.
Publicado: (2015)

Identifying and understanding disease burden in patients with inflammatory bowel disease
por: Christensen, Katrine Risager, et al.
Publicado: (2022)

The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study
por: Ishida, Natsuki, et al.
Publicado: (2020)

Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
por: Grišić, Ana‐Marija, et al.
Publicado: (2021)

Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease: A retrospective cohort study
por: Komaki, Yuga, et al.
Publicado: (2021)

Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021)

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2017)

Plasma cytokines can help to identify the development of severe acute pancreatitis on admission
por: Deng, Li-Hui, et al.
Publicado: (2017)

Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease
por: Martinez-Fierro, Margarita L., et al.
Publicado: (2019)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Influence of H. pylori CagA Coupled with Alcohol Consumption on Cytokine Profiles in Men
por: Qu, Baoge, et al.
Publicado: (2016)

The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
por: Sugiyama, Yuya, et al.
Publicado: (2023)

Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
por: Wang, Xueqi, et al.
Publicado: (2022)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study
por: Ishida, Natsuki, et al.
Publicado: (2021)

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
por: Mizoshita, Tsutomu, et al.
Publicado: (2017)

Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel disease
por: Huoponen, Saara, et al.
Publicado: (2020)

Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission
por: Miyazu, Takahiro, et al.
Publicado: (2021)

Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases
por: Deng, Yong-Qiong, et al.
Publicado: (2015)

Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile
por: Gaiani, Federica, et al.
Publicado: (2020)

Construction of gene subgroups of Crohn disease based on transcriptome data
por: Ma, Jianglei, et al.
Publicado: (2023)

Prevalence and Risk Factors of Acute Lower Gastrointestinal Bleeding in Crohn Disease
por: Li, Guanwei, et al.
Publicado: (2015)

Increased Enterococcus faecalis infection is associated with clinically active Crohn disease
por: Zhou, Youlian, et al.
Publicado: (2016)

A novel surgical predictive model for Chinese Crohn's disease patients
por: Dong, Yuan, et al.
Publicado: (2019)

Wasting condition as a marker for severe disease in pediatric Crohn's disease
por: Jin, Wook, et al.
Publicado: (2022)

An assessment of serum vitamin B12 and folate in patients with Crohn’s disease
por: Akbulut, Sabiye
Publicado: (2022)

Prognostic and therapeutic implication of m6A methylation in Crohn disease
por: He, Yujin, et al.
Publicado: (2022)

Does long-term efficacy differ between infliximab and adalimumab after 1 year of continuous administration?: A STROBE-compliant retrospective cohort study
por: Otake, Haruka, et al.
Publicado: (2017)

Clinical outcomes of endoscopic balloon dilatation of intestinal strictures in patients with Crohn's disease
por: Winder, Ophir, et al.
Publicado: (2019)

Wilson disease complicated by Crohn disease: A case report and literature review
por: Chen, Minmin, et al.
Publicado: (2023)

Immunoregulation by Naturally Occurring and Disease-Associated Autoantibodies: Binding to Cytokines and Their Role in Regulation of T-Cell Responses
por: Nielsen, Claus H., et al.
Publicado: (2012)

Small intestine contrast ultrasonography for the detection and assessment of Crohn disease: A meta-analysis
por: Zhu, Chenjing, et al.
Publicado: (2016)

Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease
por: Kawashima, Kazumasa, et al.
Publicado: (2022)

Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn’s disease
por: Park, Jin, et al.
Publicado: (2023)

Role of Exclusive Enteral Nutrition in the Preoperative Optimization of Patients With Crohn's Disease Following Immunosuppressive Therapy
por: Li, Yi, et al.
Publicado: (2015)

The clinical usefulness of a web-based messaging system between patients with Crohn disease and their physicians
por: Jeong, Da Eun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e7cmoa2f5ggtt5ch650rqlhja8